Clinical trials: Drug-Induced Retinopathy
Malignant Melanoma, Drug-Induced Retinopathy
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Patients with malignant melanoma are increasingly treated with combined BRAF and MEK inhibitor therapy. Although this treatment has significantly improved survival outcomes, it has been associated with specific retinal changes…
- Trial name
- NCT07427953
- Where
- Slovenia
- Volunteers
- 14 people
- Sponsor
- Institute of Oncology Ljubljana